Answers are grounded in this paper and cite their sources.
The role of formation science, with an emphasis on the diversity of immune responses induced by VLP, is underrepresented amongst clinical trials for VLP vaccines. Harnessing such diversity, particularly through the use of combinations of select excipients and adjuvants, will be paramount in the development of VLP vaccines.
No takes yet. Share an insight, caveat, or question.
Donaldson et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: